Evidence map›Paper›PMID 29667990›Full record

ArticleJournal of Cancer2017

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10

Wendy A Woodward, Massimo Cristofanilli, Sofia D Merajver, Steven Van Laere, Lajos Pusztai, Francois Bertucci, Fedor Berditchevski, Kornelia Polyak, Beth Overmoyer, Gayathri R Devi and 12 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Inflammatory Breast Cancer at the Extremes of Age.Annals of surgical oncology · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 4 countries.

Wendy A WoodwardMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Massimo CristofanilliDevelopmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Sofia D MerajverProgram in Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor, MI.
Steven Van LaereCenter for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp Belgium.
Lajos PusztaiBreast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT.
Francois BertucciDepartment of Medical Oncology, Institute Paoli-Calmettes, Marseille, France.
Fedor BerditchevskiSchool of Cancer Sciences of the University of Birmingham, Birmingham, United Kingdom.
Kornelia PolyakDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Beth OvermoyerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Gayathri R DeviDepartment of Surgery, Division of Surgical Sciences, Duke University Medical Sciences, Durham, NC.
Esta SterneckLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD.
Robert SchneiderDepartment of Microbiology, New York University School of Medicine, New York, NY.
Bisrat G DebebMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Xiaoping WangMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kenneth L van GolenDepartment of Biological Sciences and The Center for Translational Cancer Research, The University of Delaware, Newark, DE.
Randa El-ZeinDepartment of Radiology, Houston Methodist Research Institute, Houston, TX.
Omar M RahalMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Angela AlexanderMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
James M ReubenMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Savitri KrishnamurthyMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Anthony LucciMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
Naoto T UenoMD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.
The University of Texas MD Anderson Cancer Center · USCentre de Recherche en Cancérologie de Marseille · FRDana-Farber Cancer Institute · USDuke Medical Center · USHarvard University · USHouston Methodist · USNational Cancer Institute · USNew York University · USNorthwestern University · USUniversity of Antwerp · BEUniversity of Birmingham · GBUniversity of Delaware · USUniversity of Michigan–Ann Arbor · USYale Cancer Center · US

Funding

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor CellsZIABC010307 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI STERNECK, GISELA · 2009 to 2025
$22.1M
6 · The paper itself

Abstract

In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians and Texas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinic at MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC World Consortium of national and international experts, and launch the first ever IBC international conference in 2008, which brought together experts from around the world to facilitate collaborations and accelerate progress. Indeed great progress has been made since then. National and international experts in IBC convened at the 10

Identifiers

PMID29667990
PMCPMC5687177
OpenAlexW2766825081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.